SEARCH
CDC Advisers Recommend Pfizer RSV Vaccine for Pregnant Women
Related: display connectivity, gear, gears of the machine, Medical Industrial Complex, particulate respirators and masks, Respiratory Syncytial Virus (RSV), The Epoch Times
re: RSV
Real science is never settled, and anyone who has certainty on such things is not qualified to discuss it.
RSV (respiratory synctial virus) threatened my first-born while in the NICU 26 years ago. So I have some memory of the fear.
Vaccines carry risks
Vaccines can carry huge and unknown risks. New never-before used vaccines carry the highest risk. And here we are.
We like to think that botched vaccines are all in the past, but no one but a propagandist can make that assertion. The first RSV vaccine attempt did not go well:
Attempts to develop an RSV vaccine began in the 1960s with an unsuccessful inactivated vaccine developed by exposing the RSV virus to formalin (formalin-inactivated RSV (FI-RSV)).[19] This vaccine induced a phenomenon that came to be known as vaccine-associated enhanced respiratory disease, in which children who had not previously been exposed to RSV and were subsequently vaccinated would develop a severe form of RSV disease if exposed to the virus itself, including fever, wheezing, and bronchopneumonia.[19] Some eighty percent of such children (vs. 5% of virus-exposed controls) were hospitalized, and two children died of lethal lung inflammatory response during the first natural RSV infection after vaccination of RSV-naive infants.[19] This disaster hindered vaccine development for many years to come.[19]
CDC Advisers Recommend Pfizer RSV Vaccine for Pregnant Women
2023-09-22. Emphasis added.
The CDC's advisory committee has recommended the RSV vaccine for women in the late stages of their pregnancies.
The U.S. Centers for Disease Control and Prevention's (CDC) advisory committee on Friday recommended that expectant mothers receive the Pfizer vaccine against respiratory syncytial virus (RSV) during the late stage of their pregnancies.
The CDC's Advisory Committee on Immunization Practices voted 11 in favor of the recommendation and one opposed. The next step is formal approval from CDC Director Mandy Cohen, which is expected to make this vaccine part of the Vaccines for Children Program, further enhancing its accessibility.
[WIND:accessibilityprofitability]...RSV is responsible for numerous hospitalizations and fatalities among infants in the United States. Last week, the CDC warned that a combination of COVID-19, RSV, and influenza at the same time could overwhelm hospitals and place a burden on the U.S. health care system this winter.
...Meanwhile, some concerns have been raised regarding the potential safety risks of the Pfizer maternal RSV vaccine.
...
WIND: note the fearmongering.
IMO, it is very poor medical judgment to recommend a brand-new vaccine at-large which has no track record and unknown harms. When you read the quotes and their fearmongering, follow the money. To do so with pregnant women might end up being a net benefit (let’s hope so), but it’s also possible that unknown harms will be found, some severe or deadly. Follow the money always applies. But maybe this time all will go well and a terrific societal benefit will accrue.
But... presumably this new RSV vaccine, developed and tested and validated by the company that stands to profit handsomely (Pfizer) will be just fine. What could possibly go wrong? With the FDA bought and paid for by Big Pharma, approval has minimal credibility; it’s a very low bar.
